| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.49 | 0.003 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.41 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.37 | 0.01 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.32 | 0.05 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.3 | 0.07 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.29 | 0.01 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.29 | 0.09 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.27 | 0.06 |